Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829165 · ClinicalTrials.gov registry record · NA
Brain Imaging of rTMS Treatment for Depression
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01829165: Completed NA study, sponsored by Stanford University.
NCT01829165 is a NA study that has completed, run by Stanford University. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01829165, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The overarching goal of this research program is to elucidate causal and directional neural network- level abnormalities in depression, and how they are modulated by an individually-tailored, circuit-directed intervention. By using concurrent TMS and fMRI, the investigators can overcome a major limitation of neuroimaging - the inability to demonstrate causality. The investigators' findings will serve as a platform for future studies wherein TMS treatment can be directly guided by the investigators' ability to image and causally manipulate specific neural networks. Aim 1: To examine causal interactions between two major brain networks in depression. Aim 2: To examine the impact of antidepressant TMS on causal network abnormalities in depression. Hypothesis 1: Depressed subjects will show blunted responses, compared to healthy controls, in two targeted and interacting networks, using concurrent transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI). Hypothesis 2: Treatment of patients with high-frequency repetitive TMS (rTMS) will result in normalization of baseline network-level deficits, and be predicted by degree of baseline network abnormalities.
Interventions
- DEVICE rTMS Treatment
- DEVICE Sham rTMS Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829165
The ClinicalTrials.gov registry entry for NCT01829165 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rTMS Treatment is the first listed.
NCT01829165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01829165 about?
NCT01829165 is a clinical study titled "Brain Imaging of rTMS Treatment for Depression". The overarching goal of this research program is to elucidate causal and directional neural network- level abnormalities in depression, and how they are modulated by an individually-tailored, circuit-directed intervention. By using concurrent TMS and fMRI, the investigators can overcome a major limi...
What is the current status of trial NCT01829165?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2012-09. Estimated completion is 2017-01-20.
What interventions are being tested in trial NCT01829165?
The interventions under investigation include: rTMS Treatment (DEVICE), Sham rTMS Treatment (DEVICE).
Who is sponsoring clinical trial NCT01829165?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.